公司资料
Biotricity 股价、新闻与催化剂
- 股票代码:
- BTCY
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.06 USD (-12.02%)
收盘价
最后更新: 2026年10月1日
—
市值
股价为何变动
截至 2026年10月1日，BTCY 下跌 12.0%，收于 $0.0587。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Remote Cardiac Monitoring Company
Biotricity develops connected devices and software for cardiac diagnostics and chronic-care monitoring. Its platform links wearable sensors, cloud analytics, certified monitoring centers, and physician workflows.
Bioflux Mobile Cardiac Telemetry
Bioflux is a mobile cardiac telemetry system used to monitor patients for arrhythmias over extended periods. Data are transmitted to a monitoring center so clinically significant events can be reviewed and communicated to healthcare providers.
Biotres Extended Holter
Biotres is a wearable Holter device designed for multi-day recording and analysis. It broadens the company's diagnostic portfolio for physicians who need continuous rhythm data without full real-time telemetry.
Recurring Monitoring Economics
Biotricity generates revenue from devices, software, monitoring services, and reimbursable diagnostic tests. Growth depends on expanding the installed physician base and increasing the number of monitored patients per practice.
Consumer and Chronic-Care Products
Bioheart and related applications extend the technology into personal heart monitoring and longer-term disease management. The company is building a connected ecosystem that can support both prescribed diagnostics and ongoing patient engagement.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。